Mayank Cattle Food Limited has announced the launch of two new products, MAYANK FAT and MAYANK CAL GOLD, as part of its forward integration strategy. The announcement was made under Regulation 30 of the SEBI Listing Regulations on May 20, 2026. Both products are categorized under the Oil and Cattle Feed Industry and are aimed at the domestic market.

Product Details

The company disclosed specific details regarding the new offerings in its regulatory filing. The table below summarizes the key information for both products.

MAYANK FAT

MAYANK FAT is a specially formulated nutritional supplement designed to improve milk fat percentage in dairy animals. It addresses nutritional deficiencies that may lead to low milk fat and supports better feed utilization. The product contributes to improved milk quality and productivity, making it a supplement for dairy farmers aiming for higher returns. Key benefits include increasing milk fat percentage naturally, improving digestion and feed efficiency, and supporting healthy body weight.

MAYANK CAL GOLD

MAYANK CAL GOLD is a scientifically formulated liquid supplement intended to support dairy animals during lactation and throughout their productive cycle. It helps maintain optimal calcium balance and overall mineral nutrition, particularly during high milk production and post-calving stages. The product aims to enhance animal health, strength, and overall well-being. Benefits include increasing milk production, fulfilling calcium deficiencies, and improving immunity against diseases caused by nutritional deficiencies.

Management Commentary

Mr. Bharat Vachhani, Managing Director, stated that the launch reflects the company's continuous efforts to introduce innovative nutritional solutions. Developed with expert veterinary guidance, the products use natural ingredients to improve animal health and milk productivity. The company aims to expand its product portfolio and strengthen its market position through these offerings.

Mayank Cattle Food Limited held its Board of Directors meeting on May 11, 2026, to approve the audited standalone financial results for the half year and full financial year ended March 31, 2026. The statutory auditors, J C Ranpura & Co., issued an unmodified opinion on the financial results. The company has published these results in newspapers, including The Indian Express and Financial Express, on May 12, 2026, pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance: FY26 Full Year

The company posted a strong improvement in profitability for the full financial year, with Profit After Tax growing 21.01% and annualized EPS rising 20.96%. The following table presents the key financial highlights from the Statement of Profit and Loss:

Revenue from operations rose to Rs 4031.67 Millions in FY26 from Rs 3908.58 Millions in FY25, while Profit Before Tax increased by 16.40% to Rs 82.77 Millions. Profit After Tax demonstrated tremendous growth of 21.01%, reaching Rs 60.18 Millions compared to Rs 49.73 Millions in the prior year. Cost of material consumed stood at ₹37,113.03 lakhs, while finance costs declined to ₹326.46 lakhs from ₹364.99 lakhs, indicating improved debt management.

Half-Year Performance Comparison

The second half of FY26 demonstrated stronger performance compared to both the first half of FY26 and the corresponding period of FY25. Key metrics are presented below:

Balance Sheet Highlights

The company's total assets expanded to ₹8,478.88 lakhs as at March 31, 2026, compared to ₹7,242.95 lakhs in the prior year. Reserves and surplus improved to ₹3,268.08 lakhs from ₹2,666.26 lakhs, reflecting the accretion of profits during the year. Long-term borrowings declined to ₹405.63 lakhs from ₹530.99 lakhs, while short-term borrowings increased to ₹3,579.14 lakhs from ₹3,098.37 lakhs.

IPO Fund Utilisation and Deviation

The company disclosed a deviation in utilisation of funds raised through its Initial Public Offer. Unutilised issue proceeds of ₹74.17 lakhs, originally earmarked for capital expenditure, were reallocated towards working capital requirements. Total funds utilised stood at ₹1,943.83 lakhs, with an unutilised balance of ₹0.17 lakh retained in the Escrow IPO account.